Literature DB >> 23796996

Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months.

Christopher Straka1, D W Nathan Kim, Robert D Timmerman, Ivan Pedrosa, Corbin Jacobs, James Brugarolas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23796996      PMCID： PMC4878052          DOI： 10.1200/JCO.2012.47.7455

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  27 in total

1.  Renal-cell carcinoma--molecular pathways and therapies.

Authors:  James Brugarolas
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

2.  Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

Authors:  Robert J Motzer; Thomas E Hutson; Piotr Tomczak; M Dror Michaelson; Ronald M Bukowski; Olivier Rixe; Stéphane Oudard; Sylvie Negrier; Cezary Szczylik; Sindy T Kim; Isan Chen; Paul W Bycott; Charles M Baum; Robert A Figlin
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

3.  Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.

Authors:  Joseph K Salama; Michael D Hasselle; Steven J Chmura; Renuka Malik; Neil Mehta; Kamil M Yenice; Victoria M Villaflor; Walter M Stadler; Philip C Hoffman; Ezra E W Cohen; Philip P Connell; Daniel J Haraf; Everett E Vokes; Samuel Hellman; Ralph R Weichselbaum
Journal:  Cancer       Date:  2011-10-21       Impact factor: 6.860

Review 4.  Human cancers express mutator phenotypes: origin, consequences and targeting.

Authors:  Lawrence A Loeb
Journal:  Nat Rev Cancer       Date:  2011-05-19       Impact factor: 60.716

5.  Radiation colitis and proctitis.

Authors:  Gregory D Kennedy; Charles P Heise
Journal:  Clin Colon Rectal Surg       Date:  2007-02

6.  Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.

Authors:  Mark C Ranck; Daniel W Golden; Kimberly S Corbin; Michael D Hasselle; Stanley L Liauw; Walter M Stadler; Olwen M Hahn; Ralph R Weichselbaum; Joseph Kamel Salama
Journal:  Am J Clin Oncol       Date:  2013-12       Impact factor: 2.339

7.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

8.  Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.

Authors:  Charles C L Tong; Eric C Ko; Max W Sung; Jamie A Cesaretti; Richard G Stock; Stuart H Packer; Kevin Forsythe; Eric M Genden; Myron Schwartz; K H Vincent Lau; Matthew Galsky; Junko Ozao-Choy; Shu-Hsia Chen; Johnny Kao
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

9.  A phase II trial of sorafenib in metastatic melanoma with tissue correlates.

Authors:  Patrick A Ott; Anne Hamilton; Christina Min; Sara Safarzadeh-Amiri; Lauren Goldberg; Joanne Yoon; Herman Yee; Michael Buckley; Paul J Christos; John J Wright; David Polsky; Iman Osman; Leonard Liebes; Anna C Pavlick
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

10.  Role of radiation therapy in the management of renal cell cancer.

Authors:  Angel I Blanco; Bin S Teh; Robert J Amato
Journal:  Cancers (Basel)       Date:  2011-10-26       Impact factor: 6.639
View more
  9 in total

Review 1.  Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.

Authors:  Shankar Siva; Gargi Kothari; Alexander Muacevic; Alexander V Louie; Ben J Slotman; Bin S Teh; Simon S Lo
Journal:  Nat Rev Urol       Date:  2017-06-20       Impact factor: 14.432

Review 2.  Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma.

Authors:  Alberto Diaz de Leon; Ali Pirasteh; Daniel N Costa; Payal Kapur; Hans Hammers; James Brugarolas; Ivan Pedrosa
Journal:  Radiographics       Date:  2019-06-14       Impact factor: 5.333

3.  Stereotactic body radiotherapy for oligoprogressive cancer.

Authors:  Patrick Cheung
Journal:  Br J Radiol       Date:  2016-08-24       Impact factor: 3.039

4.  Pulsatile Clavicular Swelling as the Sole Presentation of Asymptomatic Renal Cell Carcinoma with an Isolated Metastasis to the Clavicle: A Case Report.

Authors:  Ashwani Kumar; Nitish Arora; Paras Kumar Pandove; Garima Anand; Bharti Arora
Journal:  J Clin Diagn Res       Date:  2016-12-01

5.  Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer.

Authors:  Raquibul Hannan; Michael Christensen; Hans Hammers; Alana Christie; Brendan Paulman; Dandan Lin; Aurelie Garant; Waddah Arafat; Kevin Courtney; Isaac Bowman; Suzanne Cole; David Sher; Chul Ahn; Hak Choy; Robert Timmerman; James Brugarolas
Journal:  Eur Urol Oncol       Date:  2022-01-02

Review 6.  Combining radiotherapy with sunitinib: lessons (to be) learned.

Authors:  Esther A Kleibeuker; Matthijs A Ten Hooven; Henk M Verheul; Ben J Slotman; Victor L Thijssen
Journal:  Angiogenesis       Date:  2015-07-23       Impact factor: 9.596

7.  Patterns of Progression in Metastatic Estrogen Receptor Positive Breast Cancer: An Argument for Local Therapy.

Authors:  Patrick Kelly; Zhe Ma; Said Baidas; Rebecca Moroose; Nikita Shah; Roi Dagan; Eleftherios Mamounas; Justin Rineer
Journal:  Int J Breast Cancer       Date:  2017-09-25

8.  Stereotactic body radiation therapy for oligoprogression of metastatic disease from gastrointestinal cancers: A novel approach to extend chemotherapy efficacy.

Authors:  Justin Wray; Rana Fawzi Hawamdeh; Nalini Hasija; Roi Dagan; Anamaria R Yeung; Judith L Lightsey; Paul Okunieff; Karen C Daily; Thomas J George; Robert A Zlotecki; Jose Trevino; Long H Dang
Journal:  Oncol Lett       Date:  2016-12-27       Impact factor: 2.967

9.  Outcomes of Stereotactic Body Radiotherapy for Metastatic Colorectal Cancer With Oligometastases, Oligoprogression, or Local Control of Dominant Tumors.

Authors:  Xiaoqin Ji; Yulu Zhao; Xixu Zhu; Zetian Shen; Aomei Li; Cheng Chen; Xiaoyuan Chu
Journal:  Front Oncol       Date:  2021-01-29       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.